| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| December 11th, 2008 | 33 | Yes |
Popular Name: Dasatinib Dasatinib
Find On: PubMed — Wikipedia — Google
CAS Numbers: 302962-49-8 , 302962-49-8; 863127-77-9 , 863127-77-9 , [302962-49-8] , [863127-77-9]
863127-77-9; D06414; Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN)
BMS-354825, Sprycel, BMS354825, Dasatinib
BMS-354825; anh. dasatinib; anhydrous dasatinib; dasatinib (anh.)
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.13 | 7.33 | -37.83 | 4 | 9 | 1 | 108 | 489.025 | 7 | ↓ |
| Mid Mid (pH 6-8) | 3.13 | 7.4 | -39.94 | 4 | 9 | 1 | 108 | 489.025 | 7 | ↓ |
| Mid Mid (pH 6-8) | 3.13 | 7.04 | -18.14 | 3 | 9 | 0 | 107 | 488.017 | 7 | ↓ |
| Mid Mid (pH 6-8) | 3.13 | 9.7 | -105.45 | 5 | 9 | 2 | 109 | 490.033 | 7 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 1.28e-02 g/l | DrugBank-approved |
| Purity | 95+% | Matrix Scientific |
| UniProt Database Links | ACK1_HUMAN; CSF1R_HUMAN; CSF1R_MOUSE; LYN_HUMAN; LYN_MOUSE | ChEBI |
| Therapy | antineoplastic | SMDC Pharmakon |
| Patent Database Links | EP1977765; US2004073026; US2007179125; US2007249031; US2007259869; WO2007096393; WO2007096395; WO2007109178; WO2007113268; WO2007113269; WO2007113270; WO2007116025; WO2007120726; WO2007124498; WO2007128827; WO2007128829; WO2008115973; WO2008128009; WO2008 | ChEBI |
| Warnings | IRRITANT | Matrix Scientific |
| Target | Src, Bcr-Abl, c-Kit | Selleck Chemicals |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 590 | 0.26 | Binding ≤ 10μM |
| ABL2-1-E | Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| ACK1-1-E | Tyrosine Kinase Non-receptor Protein 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.35 | Binding ≤ 10μM |
| ACV1B-1-E | Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 330 | 0.27 | Binding ≤ 10μM |
| ACVL1-1-E | Serine/threonine-protein Kinase Receptor R3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 460 | 0.27 | Binding ≤ 10μM |
| ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.26 | Binding ≤ 10μM |
| ADCK3-1-E | Chaperone Activity Of Bc1 Complex-like, Mitochondrial (cluster #1 Of 1), Eukaryotic | Eukaryotes | 190 | 0.29 | Binding ≤ 10μM |
| AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6485 | 0.22 | Binding ≤ 10μM |
| AVR2A-1-E | Activin Receptor Type-2A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.28 | Binding ≤ 10μM |
| AVR2B-1-E | Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
| BCR-1-E | Breakpoint Cluster Region Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| BLK-1-E | Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| BMX-1-E | Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| BRAF-1-E | Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
| BTK-1-E | Tyrosine-protein Kinase BTK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.35 | Binding ≤ 10μM |
| CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7 | 0.35 | Binding ≤ 10μM |
| CSK-1-E | Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| DDR2-1-E | Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3 | 0.36 | Binding ≤ 10μM |
| DMPK-1-E | Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.25 | Binding ≤ 10μM |
| E2AK4-1-E | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.25 | Binding ≤ 10μM |
| EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 79 | 0.30 | Binding ≤ 10μM |
| EPHA1-1-E | Ephrin Type-A Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
| EPHA2-1-E | Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 137 | 0.29 | Binding ≤ 10μM |
| EPHA3-1-E | Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| EPHA4-1-E | Ephrin Type-A Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| EPHA5-1-E | Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| EPHA8-1-E | Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| EPHB1-1-E | Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| EPHB2-1-E | Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
| EPHB3-1-E | Ephrin Type-B Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7 | 0.35 | Binding ≤ 10μM |
| EPHB4-1-E | Ephrin Type-B Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| ERBB2-2-E | Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 710 | 0.26 | Binding ≤ 10μM |
| FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 880 | 0.26 | Binding ≤ 10μM |
| FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.25 | Binding ≤ 10μM |
| FGR-1-E | Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8100 | 0.22 | Binding ≤ 10μM |
| FRK-1-E | Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| FYN-1-E | Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3 | 0.36 | Binding ≤ 10μM |
| HCK-1-E | Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| JAK2-1-E | Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.25 | Binding ≤ 10μM |
| KC1A-1-E | Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1500 | 0.25 | Binding ≤ 10μM |
| KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 93 | 0.30 | Binding ≤ 10μM |
| KSYK-1-E | Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2900 | 0.23 | Binding ≤ 10μM |
| LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
| LIMK1-1-E | LIM Domain Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
| LIMK2-1-E | LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 86 | 0.30 | Binding ≤ 10μM |
| LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| M3K4-1-E | Mitogen-activated Protein Kinase Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 310 | 0.28 | Binding ≤ 10μM |
| M4K1-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 980 | 0.25 | Binding ≤ 10μM |
| M4K3-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 640 | 0.26 | Binding ≤ 10μM |
| M4K4-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3100 | 0.23 | Binding ≤ 10μM |
| M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 45 | 0.31 | Binding ≤ 10μM |
| MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 410 | 0.27 | Binding ≤ 10μM |
| MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 100 | 0.30 | Binding ≤ 10μM |
| MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.30 | Binding ≤ 10μM |
| MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 495 | 0.27 | Binding ≤ 10μM |
| MLTK-1-E | Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 45 | 0.31 | Binding ≤ 10μM |
| MP2K1-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1700 | 0.24 | Binding ≤ 10μM |
| MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.24 | Binding ≤ 10μM |
| MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2000 | 0.24 | Binding ≤ 10μM |
| MRCKB-1-E | Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.24 | Binding ≤ 10μM |
| MRCKG-1-E | Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.25 | Binding ≤ 10μM |
| MST4-1-E | Serine/threonine-protein Kinase MST4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.24 | Binding ≤ 10μM |
| NLK-1-E | Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 260 | 0.28 | Binding ≤ 10μM |
| PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 63 | 0.31 | Binding ≤ 10μM |
| PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 28 | 0.32 | Binding ≤ 10μM |
| PMYT1-1-E | Tyrosine- And Threonine-specific Cdc2-inhibitory Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 130 | 0.29 | Binding ≤ 10μM |
| PTK6-1-E | Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9 | 0.34 | Binding ≤ 10μM |
| RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
| RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 730 | 0.26 | Binding ≤ 10μM |
| RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 31 | 0.32 | Binding ≤ 10μM |
| SIK1-1-E | Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
| SIK2-1-E | Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.35 | Binding ≤ 10μM |
| SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 720 | 0.26 | Binding ≤ 10μM |
| SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 14 | 0.33 | Binding ≤ 10μM |
| SRMS-1-E | Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic | Eukaryotes | 13 | 0.33 | Binding ≤ 10μM |
| STK10-1-E | Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.25 | Binding ≤ 10μM |
| STK36-1-E | Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.28 | Binding ≤ 10μM |
| TBA1A-1-E | Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic | Eukaryotes | 55 | 0.31 | Binding ≤ 10μM |
| TEC-1-E | Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic | Eukaryotes | 297 | 0.28 | Binding ≤ 10μM |
| TESK1-1-E | Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 33 | 0.32 | Binding ≤ 10μM |
| TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 230 | 0.28 | Binding ≤ 10μM |
| TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.23 | Binding ≤ 10μM |
| TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 11 | 0.34 | Binding ≤ 10μM |
| TNIK-1-E | TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2000 | 0.24 | Binding ≤ 10μM |
| TXK-1-E | Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.37 | Binding ≤ 10μM |
| VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.22 | Binding ≤ 10μM |
| VGFR2-2-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2360 | 0.24 | Binding ≤ 10μM |
| WEE1-1-E | Serine/threonine-protein Kinase WEE1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7000 | 0.22 | Binding ≤ 10μM |
| YES-1-E | Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
| Z80186-1-O | K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other | Other | 1 | 0.38 | Functional ≤ 10μM |
| Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 9 | 0.34 | Functional ≤ 10μM |
| Z81017-1-O | WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other | Other | 52 | 0.31 | Functional ≤ 10μM |
| Z81252-3-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other | Other | 12 | 0.34 | Functional ≤ 10μM |
| Z81338-1-O | T-cells (cluster #1 Of 3), Other | Other | 3 | 0.36 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 620 | 0.26 | Binding ≤ 1μM |
| ACV1B_HUMAN | P36896 | Activin Receptor Type-1B, Human | 330 | 0.27 | Binding ≤ 1μM |
| AVR2A_HUMAN | P27037 | Activin Receptor Type-2A, Human | 210 | 0.28 | Binding ≤ 1μM |
| AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 570 | 0.26 | Binding ≤ 1μM |
| BCR_HUMAN | P11274 | Breakpoint Cluster Region Protein, Human | 0.8 | 0.39 | Binding ≤ 1μM |
| KC1A_HUMAN | P48729 | Casein Kinase I Alpha, Human | 1 | 0.38 | Binding ≤ 1μM |
| ADCK3_HUMAN | Q8NI60 | Chaperone Activity Of Bc1 Complex-like, Mitochondrial, Human | 190 | 0.29 | Binding ≤ 1μM |
| DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 3.2 | 0.36 | Binding ≤ 1μM |
| MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 1000 | 0.25 | Binding ≤ 1μM |
| TESK1_HUMAN | Q15569 | Dual Specificity Testis-specific Protein Kinase 1, Human | 33 | 0.32 | Binding ≤ 1μM |
| EPHA1_HUMAN | P21709 | Ephrin Type-A Receptor 1, Human | 4.1 | 0.36 | Binding ≤ 1μM |
| EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 0.85 | 0.38 | Binding ≤ 1μM |
| EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 0.1 | 0.42 | Binding ≤ 1μM |
| EPHA4_HUMAN | P54764 | Ephrin Type-A Receptor 4, Human | 1.2 | 0.38 | Binding ≤ 1μM |
| EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 0.24 | 0.41 | Binding ≤ 1μM |
| EPHA8_HUMAN | P29322 | Ephrin Type-A Receptor 8, Human | 0.24 | 0.41 | Binding ≤ 1μM |
| EPHB1_HUMAN | P54762 | Ephrin Type-B Receptor 1, Human | 0.45 | 0.40 | Binding ≤ 1μM |
| EPHB2_HUMAN | P29323 | Ephrin Type-B Receptor 2, Human | 0.39 | 0.40 | Binding ≤ 1μM |
| EPHB3_HUMAN | P54753 | Ephrin Type-B Receptor 3, Human | 6.9 | 0.35 | Binding ≤ 1μM |
| EPHB4_HUMAN | P54760 | Ephrin Type-B Receptor 4, Human | 0.34 | 0.40 | Binding ≤ 1μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 110 | 0.30 | Binding ≤ 1μM |
| DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 0.69 | 0.39 | Binding ≤ 1μM |
| FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 880 | 0.26 | Binding ≤ 1μM |
| LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 114 | 0.29 | Binding ≤ 1μM |
| LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 86 | 0.30 | Binding ≤ 1μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 0.58 | 0.39 | Binding ≤ 1μM |
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 100 | 0.30 | Binding ≤ 1μM |
| MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 100 | 0.30 | Binding ≤ 1μM |
| MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 100 | 0.30 | Binding ≤ 1μM |
| MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 100 | 0.30 | Binding ≤ 1μM |
| M3K4_HUMAN | Q9Y6R4 | Mitogen-activated Protein Kinase Kinase Kinase 4, Human | 310 | 0.28 | Binding ≤ 1μM |
| M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 980 | 0.25 | Binding ≤ 1μM |
| M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 640 | 0.26 | Binding ≤ 1μM |
| M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 45 | 0.31 | Binding ≤ 1μM |
| MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 45 | 0.31 | Binding ≤ 1μM |
| PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 0.47 | 0.40 | Binding ≤ 1μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 0.63 | 0.39 | Binding ≤ 1μM |
| ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 710 | 0.26 | Binding ≤ 1μM |
| NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 260 | 0.28 | Binding ≤ 1μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 720 | 0.26 | Binding ≤ 1μM |
| STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 210 | 0.28 | Binding ≤ 1μM |
| BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 500 | 0.27 | Binding ≤ 1μM |
| GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 2.6 | 0.36 | Binding ≤ 1μM |
| RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 164 | 0.29 | Binding ≤ 1μM |
| ACVL1_HUMAN | P37023 | Serine/threonine-protein Kinase Receptor R3, Human | 460 | 0.27 | Binding ≤ 1μM |
| RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 109 | 0.30 | Binding ≤ 1μM |
| SIK1_HUMAN | P57059 | Serine/threonine-protein Kinase SIK1, Human | 3.9 | 0.36 | Binding ≤ 1μM |
| SIK2_HUMAN | Q9H0K1 | Serine/threonine-protein Kinase SIK2, Human | 6.4 | 0.35 | Binding ≤ 1μM |
| TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 11 | 0.34 | Binding ≤ 1μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 0.62 | 0.39 | Binding ≤ 1μM |
| TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 230 | 0.28 | Binding ≤ 1μM |
| TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 55 | 0.31 | Binding ≤ 1μM |
| ACK1_HUMAN | Q07912 | Tyrosine Kinase Non-receptor Protein 2, Human | 5.6 | 0.35 | Binding ≤ 1μM |
| PMYT1_HUMAN | Q99640 | Tyrosine- And Threonine-specific Cdc2-inhibitory Kinase, Human | 130 | 0.29 | Binding ≤ 1μM |
| ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 0.53 | 0.39 | Binding ≤ 1μM |
| ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 0.17 | 0.41 | Binding ≤ 1μM |
| BLK_MOUSE | P16277 | Tyrosine-protein Kinase BLK, Mouse | 8 | 0.34 | Binding ≤ 1μM |
| BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 0.21 | 0.41 | Binding ≤ 1μM |
| BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 1.4 | 0.38 | Binding ≤ 1μM |
| PTK6_HUMAN | Q13882 | Tyrosine-protein Kinase BRK, Human | 7.8 | 0.34 | Binding ≤ 1μM |
| BTK_HUMAN | Q06187 | Tyrosine-protein Kinase BTK, Human | 1.3 | 0.38 | Binding ≤ 1μM |
| CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 1 | 0.38 | Binding ≤ 1μM |
| FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 0.5 | 0.39 | Binding ≤ 1μM |
| FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 0.31 | 0.40 | Binding ≤ 1μM |
| FYN_HUMAN | P06241 | Tyrosine-protein Kinase FYN, Human | 0.2 | 0.41 | Binding ≤ 1μM |
| HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 0.35 | 0.40 | Binding ≤ 1μM |
| JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1000 | 0.25 | Binding ≤ 1μM |
| LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 0.1 | 0.42 | Binding ≤ 1μM |
| LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 0.2 | 0.41 | Binding ≤ 1μM |
| LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 0.57 | 0.39 | Binding ≤ 1μM |
| RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 390 | 0.27 | Binding ≤ 1μM |
| SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 0.4 | 0.40 | Binding ≤ 1μM |
| SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 0.21 | 0.41 | Binding ≤ 1μM |
| SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 13 | 0.33 | Binding ≤ 1μM |
| TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 13 | 0.33 | Binding ≤ 1μM |
| TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 0.3 | 0.40 | Binding ≤ 1μM |
| YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 0.3 | 0.40 | Binding ≤ 1μM |
| ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 620 | 0.26 | Binding ≤ 10μM |
| ACV1B_HUMAN | P36896 | Activin Receptor Type-1B, Human | 330 | 0.27 | Binding ≤ 10μM |
| AVR2A_HUMAN | P27037 | Activin Receptor Type-2A, Human | 210 | 0.28 | Binding ≤ 10μM |
| AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 570 | 0.26 | Binding ≤ 10μM |
| BCR_HUMAN | P11274 | Breakpoint Cluster Region Protein, Human | 0.8 | 0.39 | Binding ≤ 10μM |
| KC1A_HUMAN | P48729 | Casein Kinase I Alpha, Human | 1 | 0.38 | Binding ≤ 10μM |
| KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 1500 | 0.25 | Binding ≤ 10μM |
| ADCK3_HUMAN | Q8NI60 | Chaperone Activity Of Bc1 Complex-like, Mitochondrial, Human | 190 | 0.29 | Binding ≤ 10μM |
| DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 3.2 | 0.36 | Binding ≤ 10μM |
| MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 1000 | 0.25 | Binding ≤ 10μM |
| MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 1400 | 0.25 | Binding ≤ 10μM |
| TESK1_HUMAN | Q15569 | Dual Specificity Testis-specific Protein Kinase 1, Human | 33 | 0.32 | Binding ≤ 10μM |
| EPHA1_HUMAN | P21709 | Ephrin Type-A Receptor 1, Human | 4.1 | 0.36 | Binding ≤ 10μM |
| EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 0.85 | 0.38 | Binding ≤ 10μM |
| EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 0.1 | 0.42 | Binding ≤ 10μM |
| EPHA4_HUMAN | P54764 | Ephrin Type-A Receptor 4, Human | 1.2 | 0.38 | Binding ≤ 10μM |
| EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 0.24 | 0.41 | Binding ≤ 10μM |
| EPHA8_HUMAN | P29322 | Ephrin Type-A Receptor 8, Human | 0.24 | 0.41 | Binding ≤ 10μM |
| EPHB1_HUMAN | P54762 | Ephrin Type-B Receptor 1, Human | 0.45 | 0.40 | Binding ≤ 10μM |
| EPHB2_HUMAN | P29323 | Ephrin Type-B Receptor 2, Human | 0.39 | 0.40 | Binding ≤ 10μM |
| EPHB3_HUMAN | P54753 | Ephrin Type-B Receptor 3, Human | 6.9 | 0.35 | Binding ≤ 10μM |
| EPHB4_HUMAN | P54760 | Ephrin Type-B Receptor 4, Human | 0.34 | 0.40 | Binding ≤ 10μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 110 | 0.30 | Binding ≤ 10μM |
| DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 0.69 | 0.39 | Binding ≤ 10μM |
| E2AK4_HUMAN | Q9P2K8 | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4, Human | 1600 | 0.25 | Binding ≤ 10μM |
| FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 3700 | 0.23 | Binding ≤ 10μM |
| FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 1400 | 0.25 | Binding ≤ 10μM |
| LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 114 | 0.29 | Binding ≤ 10μM |
| LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 86 | 0.30 | Binding ≤ 10μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 0.58 | 0.39 | Binding ≤ 10μM |
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 100 | 0.30 | Binding ≤ 10μM |
| MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 100 | 0.30 | Binding ≤ 10μM |
| MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 100 | 0.30 | Binding ≤ 10μM |
| MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 100 | 0.30 | Binding ≤ 10μM |
| M3K4_HUMAN | Q9Y6R4 | Mitogen-activated Protein Kinase Kinase Kinase 4, Human | 310 | 0.28 | Binding ≤ 10μM |
| M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 980 | 0.25 | Binding ≤ 10μM |
| M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 640 | 0.26 | Binding ≤ 10μM |
| M4K4_HUMAN | O95819 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4, Human | 3100 | 0.23 | Binding ≤ 10μM |
| M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 45 | 0.31 | Binding ≤ 10μM |
| MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 45 | 0.31 | Binding ≤ 10μM |
| DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 1300 | 0.25 | Binding ≤ 10μM |
| PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 0.47 | 0.40 | Binding ≤ 10μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 0.63 | 0.39 | Binding ≤ 10μM |
| ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 1400 | 0.25 | Binding ≤ 10μM |
| NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 260 | 0.28 | Binding ≤ 10μM |
| STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 1200 | 0.25 | Binding ≤ 10μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 720 | 0.26 | Binding ≤ 10μM |
| STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 210 | 0.28 | Binding ≤ 10μM |
| AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 6485 | 0.22 | Binding ≤ 10μM |
| BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 500 | 0.27 | Binding ≤ 10μM |
| GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 2.6 | 0.36 | Binding ≤ 10μM |
| MRCKB_HUMAN | Q9Y5S2 | Serine/threonine-protein Kinase MRCK Beta, Human | 2100 | 0.24 | Binding ≤ 10μM |
| MRCKG_HUMAN | Q6DT37 | Serine/threonine-protein Kinase MRCK Gamma, Human | 1200 | 0.25 | Binding ≤ 10μM |
| MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 2000 | 0.24 | Binding ≤ 10μM |
| MST4_HUMAN | Q9P289 | Serine/threonine-protein Kinase MST4, Human | 1900 | 0.24 | Binding ≤ 10μM |
| RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 164 | 0.29 | Binding ≤ 10μM |
| ACVL1_HUMAN | P37023 | Serine/threonine-protein Kinase Receptor R3, Human | 460 | 0.27 | Binding ≤ 10μM |
| RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 109 | 0.30 | Binding ≤ 10μM |
| SIK1_HUMAN | P57059 | Serine/threonine-protein Kinase SIK1, Human | 3.9 | 0.36 | Binding ≤ 10μM |
| SIK2_HUMAN | Q9H0K1 | Serine/threonine-protein Kinase SIK2, Human | 6.4 | 0.35 | Binding ≤ 10μM |
| TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 11 | 0.34 | Binding ≤ 10μM |
| WEE1_HUMAN | P30291 | Serine/threonine-protein Kinase WEE1, Human | 7000 | 0.22 | Binding ≤ 10μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 0.62 | 0.39 | Binding ≤ 10μM |
| TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 230 | 0.28 | Binding ≤ 10μM |
| TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 2900 | 0.23 | Binding ≤ 10μM |
| TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 2000 | 0.24 | Binding ≤ 10μM |
| TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 55 | 0.31 | Binding ≤ 10μM |
| ACK1_HUMAN | Q07912 | Tyrosine Kinase Non-receptor Protein 2, Human | 5.6 | 0.35 | Binding ≤ 10μM |
| PMYT1_HUMAN | Q99640 | Tyrosine- And Threonine-specific Cdc2-inhibitory Kinase, Human | 130 | 0.29 | Binding ≤ 10μM |
| ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 0.53 | 0.39 | Binding ≤ 10μM |
| ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 0.17 | 0.41 | Binding ≤ 10μM |
| BLK_MOUSE | P16277 | Tyrosine-protein Kinase BLK, Mouse | 8 | 0.34 | Binding ≤ 10μM |
| BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 0.21 | 0.41 | Binding ≤ 10μM |
| BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 1.4 | 0.38 | Binding ≤ 10μM |
| PTK6_HUMAN | Q13882 | Tyrosine-protein Kinase BRK, Human | 7.8 | 0.34 | Binding ≤ 10μM |
| BTK_HUMAN | Q06187 | Tyrosine-protein Kinase BTK, Human | 1.3 | 0.38 | Binding ≤ 10μM |
| CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 1 | 0.38 | Binding ≤ 10μM |
| FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 0.5 | 0.39 | Binding ≤ 10μM |
| FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 0.31 | 0.40 | Binding ≤ 10μM |
| FYN_HUMAN | P06241 | Tyrosine-protein Kinase FYN, Human | 0.2 | 0.41 | Binding ≤ 10μM |
| HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 0.35 | 0.40 | Binding ≤ 10μM |
| JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1000 | 0.25 | Binding ≤ 10μM |
| LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 0.1 | 0.42 | Binding ≤ 10μM |
| LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 0.2 | 0.41 | Binding ≤ 10μM |
| LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 0.57 | 0.39 | Binding ≤ 10μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 8100 | 0.22 | Binding ≤ 10μM |
| RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 2100 | 0.24 | Binding ≤ 10μM |
| SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 0.21 | 0.41 | Binding ≤ 10μM |
| SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 0.4 | 0.40 | Binding ≤ 10μM |
| SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 13 | 0.33 | Binding ≤ 10μM |
| KSYK_HUMAN | P43405 | Tyrosine-protein Kinase SYK, Human | 2900 | 0.23 | Binding ≤ 10μM |
| TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 13 | 0.33 | Binding ≤ 10μM |
| TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 0.3 | 0.40 | Binding ≤ 10μM |
| YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 0.3 | 0.40 | Binding ≤ 10μM |
| VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 5000 | 0.22 | Binding ≤ 10μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 2360 | 0.24 | Binding ≤ 10μM |
| Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 1 | 0.38 | Functional ≤ 10μM |
| Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 12 | 0.34 | Functional ≤ 10μM |
| Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 9.4 | 0.34 | Functional ≤ 10μM |
| Z81338 | Z81338 | T-cells | 3 | 0.36 | Functional ≤ 10μM |
| Z81017 | Z81017 | WiDr (Colon Adenocarcinoma Cells) | 52 | 0.31 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Activated point mutants of FGFR2 | |
| activated TAK1 mediates p38 MAPK activation | |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
| Activation of the AP-1 family of transcription factors | |
| ADP signalling through P2Y purinoceptor 1 | |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
| APC truncation mutants have impaired AXIN binding | |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
| Apoptotic cleavage of cellular proteins | |
| ARMS-mediated activation | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| c-src mediated regulation of Cx43 function and closure of gap junctions | |
| Ca2+ pathway | |
| CD28 co-stimulation | |
| CD28 dependent PI3K/Akt signaling | |
| CD28 dependent Vav1 pathway | |
| CDO in myogenesis | |
| Cell surface interactions at the vascular wall | |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
| Circadian Clock | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| CREB phosphorylation through the activation of Ras | |
| CRMPs in Sema3A signaling | |
| CTLA4 inhibitory signaling | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin A:Cdk2-associated events at S phase entry | |
| Cyclin E associated events during G1/S transition | |
| DAP12 signaling | |
| DCC mediated attractive signaling | |
| Degradation of beta-catenin by the destruction complex | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| Downregulation of ERBB2:ERBB3 signaling | |
| Downregulation of TGF-beta receptor signaling | |
| Downstream signal transduction | |
| Downstream TCR signaling | |
| DSCAM interactions | |
| EGFR downregulation | |
| EGFR interacts with phospholipase C-gamma | |
| EGFR Transactivation by Gastrin | |
| EPH-ephrin mediated repulsion of cells | |
| EPH-Ephrin signaling | |
| EPHA-mediated growth cone collapse | |
| EPHB-mediated forward signaling | |
| Ephrin signaling | |
| ERK/MAPK targets | |
| ERK1 activation | |
| ERK2 activation | |
| Factors involved in megakaryocyte development and platelet production | |
| Fc epsilon receptor (FCERI) signaling | |
| FCERI mediated Ca+2 mobilization | |
| FCERI mediated MAPK activation | |
| FCERI mediated NF-kB activation | |
| FCGR activation | |
| Formation of tubulin folding intermediates by CCT/TriC | |
| Frs2-mediated activation | |
| G2/M DNA replication checkpoint | |
| GAB1 signalosome | |
| Gap junction assembly | |
| Generation of second messenger molecules | |
| Golgi Associated Vesicle Biogenesis | |
| GP1b-IX-V activation signalling | |
| GPVI-mediated activation cascade | |
| GRB2 events in EGFR signaling | |
| GRB2 events in ERBB2 signaling | |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | |
| GRB7 events in ERBB2 signaling | |
| Growth hormone receptor signaling | |
| Integrin alphaIIb beta3 signaling | |
| Integrin cell surface interactions | |
| Interferon gamma signaling | |
| Interleukin receptor SHC signaling | |
| Interleukin-1 signaling | |
| Interleukin-2 signaling | |
| Interleukin-3, 5 and GM-CSF signaling | |
| Interleukin-6 signaling | |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
| Kinesins | |
| KSRP destabilizes mRNA | |
| L1CAM interactions | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| MEK activation | |
| MHC class II antigen presentation | |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| Mitotic Prometaphase | |
| MyD88:Mal cascade initiated on plasma membrane | |
| NCAM signaling for neurite out-growth | |
| Nef and signal transduction | |
| Nef Mediated CD4 Down-regulation | |
| Nephrin interactions | |
| Netrin mediated repulsion signals | |
| Neurophilin interactions with VEGF and VEGFR | |
| NOD1/2 Signaling Pathway | |
| Non-integrin membrane-ECM interactions | |
| Oxidative Stress Induced Senescence | |
| p130Cas linkage to MAPK signaling for integrins | |
| p38MAPK events | |
| p75NTR recruits signalling complexes | |
| PD-1 signaling | |
| PECAM1 interactions | |
| Phosphorylation of CD3 and TCR zeta chains | |
| PI3K events in ERBB2 signaling | |
| PIP3 activates AKT signaling | |
| Platelet Adhesion to exposed collagen | |
| Platelet sensitization by LDL | |
| PLCG1 events in ERBB2 signaling | |
| Polo-like kinase mediated events | |
| Post-chaperonin tubulin folding pathway | |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | |
| Prefoldin mediated transfer of substrate to CCT/TriC | |
| Prolactin receptor signaling | |
| RAF activation | |
| RAF phosphorylates MEK | |
| Rap1 signalling | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Recruitment of NuMA to mitotic centrosomes | |
| Recycling pathway of L1 | |
| Regulation of actin dynamics for phagocytic cup formation | |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen | |
| Regulation of IFNG signaling | |
| Regulation of KIT signaling | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Regulation of signaling by CBL | |
| Regulation of signaling by NODAL | |
| Resolution of Sister Chromatid Cohesion | |
| Rho GTPase cycle | |
| RMTs methylate histone arginines | |
| Role of Abl in Robo-Slit signaling | |
| Role of LAT2/NTAL/LAB on calcium mobilization | |
| Role of phospholipids in phagocytosis | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| Sema3A PAK dependent Axon repulsion | |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | |
| Sema4D induced cell migration and growth-cone collapse | |
| Separation of Sister Chromatids | |
| SHC1 events in EGFR signaling | |
| SHC1 events in ERBB2 signaling | |
| Signal regulatory protein (SIRP) family interactions | |
| Signal transduction by L1 | |
| Signaling by activated point mutants of FGFR1 | |
| Signaling by Activin | |
| Signaling by BMP | |
| Signaling by constitutively active EGFR | |
| Signaling by EGFR | |
| Signaling by ERBB2 | |
| Signaling by ERBB4 | |
| Signaling by FGFR | |
| Signaling by FGFR mutants | |
| Signaling by FGFR1 fusion mutants | |
| Signaling by FGFR2 amplification mutants | |
| Signaling by Leptin | |
| Signaling by NODAL | |
| Signaling by PDGF | |
| Signaling by SCF-KIT | |
| Signalling to p38 via RIT and RIN | |
| SMAD2/3 MH2 Domain Mutants in Cancer | |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
| Spry regulation of FGF signaling | |
| Stimuli-sensing channels | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
| TGF-beta receptor signaling activates SMADs | |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
| TGFBR1 KD Mutants in Cancer | |
| TGFBR1 LBD Mutants in Cancer | |
| TGFBR2 Kinase Domain Mutants in Cancer | |
| TGFBR2 MSI Frameshift Mutants in Cancer | |
| Thrombin signalling through proteinase activated receptors (PARs) | |
| Translocation of GLUT4 to the plasma membrane | |
| Translocation of ZAP-70 to Immunological synapse | |
| truncations of AMER1 destabilize the destruction complex | |
| Uptake and function of anthrax toxins | |
| VEGF binds to VEGFR leading to receptor dimerization | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation | |
| WNT mediated activation of DVL |